

Please try another search
Intra-Cellular Therapies (NASDAQ:ITCI) reported Q1 EPS of ($0.78), $0.14 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $35 million versus the consensus estimate of...
Leerink Partners analyst Marc Goodman maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Monday, setting a price target of $50, which is approximately 10.25% above the present share...
Needham analyst Ami Fadia maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Monday, setting a price target of $55, which is approximately 51.47% above the present share price of...
Leerink Partners analyst Marc Goodman reiterated a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Tuesday, setting a price target of $45, which is approximately 16.76% above the present share...
Needham analyst Ami Fadia reiterated a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Tuesday, setting a price target of $55, which is approximately 31.93% above the present share price of...
Needham analyst Ami Fadia maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Wednesday, setting a price target of $55, which is approximately 47.97% above the present share price of...
Jefferies (NYSE:JEF) analyst Andrew Tsai maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Saturday, setting a price target of $70, which is approximately 103.73% above the present...
RBC Capital analyst Brian Abrahams maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Thursday, setting a price target of $47, which is approximately 15.37% above the present share...
Leerink Partners analyst Marc Goodman reiterated a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Monday, setting a price target of $45, which is approximately 19.87% above the present share...
BTIG analyst Robert Hazlett maintained a Buy rating on Intra-Cellular Therapies (NASDAQ:ITCI) on Monday, setting a price target of $40, which is approximately 11.20% above the present share price of...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review